Multi-Center Study for the Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
Conditions: Wilson Disease
Sponsor: Alexion Pharmaceuticals, Inc.

Multi-Center Study for the Assessment of Copper 
Parameters in Wilson Disease Subjects on Standard of Care 
Treatment 
 
 
Unique Protocol ID: 
WTX101-203 
NCT Number: 
NCT02763215 
EudraCT Number:  
2015-005796-24 
Date of Protocol:  
21 September 2016 
 

PPD
PPD
PPD
PPD
PPD
PPD
PPD
PPD
PPD